Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Cunningham

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2017
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapseFrançois M J Lamoury, Angelica Soker, Danica Martinez, et al.
Plos Neglected Tropical Diseases|April 19, 2022
A national survey integrating clinical, laboratory, and WASH data to determine the typology of trachoma in NauruKathleen D Lynch, Sue Chen Apadinuwe, Stephen B Lambert, et al.
AIDS (London, England)|June 21, 2021
HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activityKazuo Suzuki, Angelique Levert, Julie Yeung, et al.
The Journal of Infectious Diseases|March 14, 2018
Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care AssayFrancois M J Lamoury, Sahar Bajis, Behzad Hajarizadeh, et al.
Expert Review of Molecular Diagnostics|December 25, 2024
Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care - Real world lessons from remote AustraliaTanya L Applegate, Louise M Causer, Ineka Gow, et al.
Frontiers in Immunology|December 22, 2022
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cellsChansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, et al.
NPJ Precision Oncology|May 7, 2026
A roadmap for establishing institutional readiness for cellular therapies targeting solid tumours and autoimmune diseasesSarah Childs, David Ma, Elizabeth Houghton, et al.
Plos Medicine|July 6, 2021
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variantsFiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2017
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapseFrançois M J Lamoury, Angelica Soker, Danica Martinez, et al.
Plos Neglected Tropical Diseases|April 19, 2022
A national survey integrating clinical, laboratory, and WASH data to determine the typology of trachoma in NauruKathleen D Lynch, Sue Chen Apadinuwe, Stephen B Lambert, et al.
AIDS (London, England)|June 21, 2021
HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activityKazuo Suzuki, Angelique Levert, Julie Yeung, et al.
The Journal of Infectious Diseases|March 14, 2018
Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care AssayFrancois M J Lamoury, Sahar Bajis, Behzad Hajarizadeh, et al.
Expert Review of Molecular Diagnostics|December 25, 2024
Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care - Real world lessons from remote AustraliaTanya L Applegate, Louise M Causer, Ineka Gow, et al.
Frontiers in Immunology|December 22, 2022
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cellsChansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, et al.
NPJ Precision Oncology|May 7, 2026
A roadmap for establishing institutional readiness for cellular therapies targeting solid tumours and autoimmune diseasesSarah Childs, David Ma, Elizabeth Houghton, et al.
Plos Medicine|July 6, 2021
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variantsFiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
Pageof 6